TERM ID="NYU_TERM_1" STRING="ABL mutations" FREQUENCY=1 START=1393 END=1406 LEMMA="ABL MUTATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="BCR-ABL TKIs" FREQUENCY=1 START=464 END=476 LEMMA="BCR-ABL TKI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_3" STRING="BCR-ABL inhibitor" FREQUENCY=1 START=1009 END=1026 LEMMA="BCR-ABL INHIBITOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_4" STRING="CML" FREQUENCY=1 START=279 END=282 LEMMA="CML" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="Clinical roundtable monograph" FREQUENCY=1 START=0 END=29 LEMMA="CLINICAL ROUNDTABLE MONOGRAPH" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="Continuous treatment" FREQUENCY=1 START=637 END=657 LEMMA="CONTINUOUS TREATMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="Emerging treatment options" FREQUENCY=1 START=31 END=57 LEMMA="EMERGING TREATMENT OPTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="Emerging treatment options for TKI-resistant chronic myelogenous leukemia" FREQUENCY=1 START=31 END=104 LEMMA="TKI-RESISTANT CHRONIC MYELOGENOUS LEUKEMIA EMERGING TREATMENT OPTION" LEMMA_FREQUENCY=1 HEAD_TERM="Emerging treatment options" HEAD_LEMMA="EMERGING TREATMENT OPTION"
TERM ID="NYU_TERM_9" STRING="TKI resistance" FREQUENCY=2 START=1302 END=1316 LEMMA="TKI RESISTANCE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_10" STRING="TKI resistance" FREQUENCY=2 START=1355 END=1369 LEMMA="TKI RESISTANCE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_11" STRING="TKI-resistant chronic myelogenous leukemia" FREQUENCY=1 START=62 END=104 LEMMA="TKI-RESISTANT CHRONIC MYELOGENOUS LEUKEMIA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="TKIs" FREQUENCY=1 START=152 END=156 LEMMA="TYROSINE KINASE INHIBITORS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="TKIs dasatinib" FREQUENCY=1 START=595 END=609 LEMMA="TKIS DASATINIB" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="allogeneic stem cell transplantation" FREQUENCY=1 START=377 END=413 LEMMA="ALLOGENEIC STEM CELL TRANSPLANTATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_15" STRING="alternative therapies" FREQUENCY=1 START=926 END=947 LEMMA="ALTERNATIVE THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="bosutinib" FREQUENCY=1 START=626 END=635 LEMMA="BOSUTINIB" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="change therapies" FREQUENCY=1 START=1481 END=1497 LEMMA="CHANGE THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_18" STRING="chronic myelogenous leukemia" FREQUENCY=2 START=249 END=277 LEMMA="CHRONIC MYELOGENOUS LEUKEMIA" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_19" STRING="chronic myelogenous leukemia" FREQUENCY=2 START=249 END=277 LEMMA="CHRONIC MYELOGENOUS LEUKEMIA" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_20" STRING="chronic-phase CML" FREQUENCY=1 START=740 END=757 LEMMA="CHRONIC-PHASE CML" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="clinical activity" FREQUENCY=1 START=1249 END=1266 LEMMA="CLINICAL ACTIVITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="constitutive BCR-ABL protein" FREQUENCY=1 START=188 END=216 LEMMA="CONSTITUTIVE BCR-ABL PROTEIN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_23" STRING="first-generation TKI imatinib" FREQUENCY=1 START=538 END=567 LEMMA="FIRST-GENERATION TKI IMATINIB" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="homoharringtonine derivative omacetaxine mepesuccinate" FREQUENCY=1 START=1137 END=1191 LEMMA="HOMOHARRINGTONINE DERIVATIVE OMACETAXINE MEPESUCCINATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="nilotinib" FREQUENCY=1 START=611 END=620 LEMMA="NILOTINIB" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="protein synthesis" FREQUENCY=1 START=1208 END=1225 LEMMA="PROTEIN SYNTHESIS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_27" STRING="salvage setting" FREQUENCY=1 START=442 END=457 LEMMA="SALVAGE SETTING" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_28" STRING="second-generation" FREQUENCY=1 START=577 END=594 LEMMA="SECOND-GENERATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_29" STRING="second-generation TKIs dasatinib" FREQUENCY=1 START=577 END=609 LEMMA="TKIS DASATINIB SECOND-GENERATION" LEMMA_FREQUENCY=1 HEAD_TERM="TKIs dasatinib" HEAD_LEMMA="TKIS DASATINIB"
TERM ID="NYU_TERM_30" STRING="third-generation TKI ponatinib" FREQUENCY=1 START=973 END=1003 LEMMA="THIRD-GENERATION TKI PONATINIB" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_31" STRING="treatment landscape" FREQUENCY=1 START=328 END=347 LEMMA="TREATMENT LANDSCAPE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_32" STRING="tyrosine kinase inhibitors" FREQUENCY=2 START=124 END=150 LEMMA="TYROSINE KINASE INHIBITOR" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_33" STRING="tyrosine kinase inhibitors" FREQUENCY=2 START=124 END=150 LEMMA="TYROSINE KINASE INHIBITOR" LEMMA_FREQUENCY=2
